Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two-hit mechanism of NF2 inactivation

Genes Chromosomes and Cancer

Volumn 24, Issue 3, 1999, Pages 238-242

  Cheng, Jin Quan ^a   Lee, Wen Ching ^a   Klein, Matias A ^a   Cheng, George Z ^a   Jhanwar, Suresh C ^b   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ALLELE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMOSOME 22Q; CHROMOSOME BAND; CHROMOSOME INACTIVATION; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; MESOTHELIOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; WESTERN BLOTTING;

BLOTTING, WESTERN; CHROMOSOMES, HUMAN, PAIR 22; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEUROFIBROMATOSIS 2; HUMANS; LOSS OF HETEROZYGOSITY; MEMBRANE PROTEINS; MESOTHELIOMA; MUTATION; NEOPLASM PROTEINS; NEUROFIBROMIN 2; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR CELLS, CULTURED;

EID: 0001387683     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199903)24:3<238::AID-GCC9>3.0.CO;2-M     Document Type: Article

References (29)

1. Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y. 1994. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet 3:565-568.
2. Arpin M, Algrain M, Louvard D. 1994. Membrane-actin microfilament connections: An increasing diversity of players related to band 4.1. Current Opin Cell Biol 6:136-141.
3. Blanchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJP, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR, Kley N. 1994. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 6:185-192.
4. Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJP, Testa JR. 1995. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci USA 92:10854-10858.
5. Bourn D, Strachan T. 1994. Dinucleotide repeat polymorphism at the NF2 gene. Hum Molec Genet 3:1914.
6. Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, Nobori T, Olopade OI, Buckler AJ, Testa JR. 1994. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54:5547-5551.
7. Cheng JQ, Altomare DA, Klein MA, Lee W-C, Kruh GD, Lissy NA, Testa JR. 1997. Transforming activity and mitosis-related expression of the AKT2 oncogene: Evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene 14:2793-2801.
8. Craighead JE, Mossman BT. 1982. The pathogenesis of asbestos-associated diseases. N Engl J Med 306:1446-1455.
9. Hitotsumatsu T, Iwaki T, Kitamoto T, Mizoguchi M, Suzuki SO, Hamada Y, Fukui M, Tateishi J. 1997. Expression of neurofibromatosis 2 protein in human brain tumors: An immunohistochemical study. Acta Neuropathologica 93:225-232.
10. Hoang-Xuan K, Merel P, Vega F, Hugot J-P, Cornu P, Delattre J-Y, Poisson M, Thomas G, Delattre O. 1945. Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. Im J Cancer 60:478-481.
11. Jacobs LB, MacCollin M, Louis DN, Mohney T, Rubio M-P, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V, Gusella J. 1994. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413-419.
12. Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF. 1996. Frequency and distribution of NF2 mutations in schuannonias. Genes Chromosomes Cancer 17:45-55.
13. Kley N, Seizinger BR. 1995. The neurofibromatosis 2 (NF2) tumor suppressor gene: Implications beyond the hereditary tumor syndrome? Cancer Surveys 25:207-218.
14. Knudson AG Jr. 1996. Hereditary cancer: Two-hits revisited. J Cancer Res Clin Oncol 122:135-140.
15. Luna EJ, Hitt AL. 1992. Cytoskeleton-plasma membrane interactions. Science 258:955-964.
16. Martuza RL, Eldridge R. 1988. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 318:684-688.
17. Merel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, Delattre JY, Poisson M, Theillet C, Hulsebos T, Delattre O, Thomas G. 1995. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer 13:211-216.
18. Rodriguez E, Rao PH, Ladanyi M, Altorki N, Albino AP, Kelsen DP, Jhanwar SC, Chaganti RS. 1990. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res 50:6410-6416.
19. Rouleau GA, Wertelecki W, Haines JL, Hobbs WJ, Trofatter JA, Seizinger JA, Martuza RL, Superneau DW, Conneally PM, Gusella JF. 1987. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329:246-248.
20. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldridge R, Aurias A, Delattre O, Thomas G. 1993. Altetation in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363:515-521.
21. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor, p 9.16-9.19.
22. Seizinger BR, Martuza RL, Gusella JF. 1986. Loss of genes on chromosome 22 in the tumorigenesis of human acoustic neuroma. Nature 322:644-647.
23. Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD. 1995. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55:1227-1231.
24. Sherman L, Xu H-M, Geist RT, Saporito-Irwin S, Howells N, Ponta H, Herrlich P, Gutmann DH. 1997. Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene 15:2505-2509.
25. Smith DB, Corcoran LM. 1994. Expression and purification of glutathione S-transferase fusion proteins. In Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current protocols in molecular biology. New York: John Wiley & Sons, p 16.7.1-16.7.7.
26. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR. 1993. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53:4349-4355.
27. Tiainen M, Tammilehto L, Mattson K, Knuutila S. 1988. Nonrandom chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet Cytogenet 33:251-274.
28. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Hasse V, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF. 1993. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800.
29. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA. 1994. The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151.